Connection

Cristina Gervasoni to Lopinavir

Back to Details
This is a "connection" page, showing publications Cristina Gervasoni has written about Lopinavir.
Cristina Gervasoni
Connection Strength
0.394
Lopinavir
  1. Prediction of lopinavir/ritonavir effectiveness in COVID-19 patients: a recall of basic pharmacology concepts. Eur J Clin Pharmacol. 2021 05; 77(5):791-792.
    View in: PubMed
    Score: 0.076
  2. Drug-Drug Interactions and Prescription Appropriateness in Patients with COVID-19: A Retrospective Analysis from a Reference Hospital in Northern Italy. Drugs Aging. 2020 12; 37(12):925-933.
    View in: PubMed
    Score: 0.076
  3. Early administration of lopinavir/ritonavir plus hydroxychloroquine does not alter the clinical course of SARS-CoV-2 infection: A retrospective cohort study. J Med Virol. 2021 03; 93(3):1421-1427.
    View in: PubMed
    Score: 0.075
  4. Lopinavir/ritonavir in COVID-19 patients: maybe yes, but at what dose? J Antimicrob Chemother. 2020 09 01; 75(9):2704-2706.
    View in: PubMed
    Score: 0.075
  5. Darunavir does not prevent SARS-CoV-2 infection in HIV patients. Pharmacol Res. 2020 07; 157:104826.
    View in: PubMed
    Score: 0.073
  6. Does lopinavir really inhibit SARS-CoV-2? Pharmacol Res. 2020 08; 158:104898.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.